Johnson & Johnson (JNJ)
283.52
+3.11
(+1.11%)
USD |
NYSE |
Nov 12, 16:00
284.00
+0.48
(+0.17%)
Pre-Market: 04:38
Johnson & Johnson Free Cash Flow (Quarterly) : 5.363B for Sept. 30, 2026
Free Cash Flow (Quarterly) Chart
Historical Free Cash Flow (Quarterly) Data
| Date | Value |
|---|---|
| September 30, 2026 | 5.363B |
| June 30, 2026 | 7.295B |
| March 31, 2026 | 1.465B |
| December 31, 2025 | 5.857B |
| September 30, 2025 | 7.996B |
| June 30, 2025 | 2.48B |
| March 31, 2025 | 3.365B |
| December 31, 2024 | 6.621B |
| September 30, 2024 | 5.714B |
| June 30, 2024 | 4.657B |
| March 31, 2024 | 2.85B |
| December 31, 2023 | 6.274B |
| September 30, 2023 | 6.522B |
| June 30, 2023 | 3.058B |
| March 31, 2023 | 2.394B |
| December 31, 2022 | 3.763B |
| September 30, 2022 | 5.332B |
| June 30, 2022 | 4.718B |
| March 31, 2022 | 3.372B |
| December 31, 2021 | 4.317B |
| September 30, 2021 | 7.543B |
| June 30, 2021 | 4.501B |
| March 31, 2021 | 3.397B |
| December 31, 2020 | 7.02B |
| September 30, 2020 | 7.646B |
| Date | Value |
|---|---|
| June 30, 2020 | 2.79B |
| March 31, 2020 | 2.733B |
| December 31, 2019 | 5.138B |
| September 30, 2019 | 6.782B |
| June 30, 2019 | 5.111B |
| March 31, 2019 | 2.887B |
| December 31, 2018 | 4.926B |
| September 30, 2018 | 5.453B |
| June 30, 2018 | 5.204B |
| March 31, 2018 | 2.948B |
| December 31, 2017 | 4.865B |
| September 30, 2017 | 5.476B |
| June 30, 2017 | 5.083B |
| March 31, 2017 | 2.353B |
| December 31, 2016 | 5.56B |
| September 30, 2016 | 4.624B |
| June 30, 2016 | 3.807B |
| March 31, 2016 | 1.55B |
| December 31, 2015 | 3.716B |
| September 30, 2015 | 5.336B |
| June 30, 2015 | 4.435B |
| March 31, 2015 | 2.329B |
| December 31, 2014 | 2.869B |
| September 30, 2014 | 3.903B |
| June 30, 2014 | 4.692B |
Free Cash Flow Definition
Free Cash Flow is the cash a company has left after paying for its day-to-day operations and investing in its physical assets, such as buildings, equipment and technology. The company can use that cash however it chooses: paying dividends, buying back shares, paying down debt, making acquisitions or keeping it for future growth.
Free Cash Flow (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow (Quarterly) Benchmarks
| Eli Lilly & Co. | 4.157B |
| Merck & Co., Inc. | 5.518B |
| Pfizer Inc. | 4.802B |
| Bristol Myers Squibb Co. | 3.837B |
| Abbott Laboratories | 1.224B |